Product Information

CELECOXIB 200 MG CAPSULE is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.0770 per EA under NDC 62332014271. Its NADAC has been published 490 times since Jul 5, 2017.

FDA first approved this application on Aug 21, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CELECOXIB 200 MG CAPSULE

Celecoxib
$0.0770per EA

Strength

200 mg/1

NDC

62332014271

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

CELECOXIB

Approval Type

Generic (ANDA)

FDA Application

ANDA204519

FDA Approved

8/21/2015

TE Code

AB

On Market Since

12/1/2015

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for CELECOXIB 200 MG CAPSULE has been published 490 times since Jul 5, 2017, and over the history we have for it it has declined 81.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0770 per EA
All-time high$0.4244 (Aug 16, 2017)
All-time low$0.0749 (Oct 21, 2026)
52-week high$0.0866
52-week low$0.0749
Median price$0.1436
Average price$0.1563
Largest weekly change+25.0% (Aug 21, 2024)
Weeks tracked490
Tracking sinceJul 5, 2017

Price History

1W

+2.7%

1M

+1.0%

3M

+1.3%

6M

-7.9%

1Y

-11.6%

3Y

-30.0%

5Y

-51.0%

All

-81.8%

Generic Alternatives

The matcher finds 17 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CELECOXIB 200 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for CELECOXIB 200 MG CAPSULE, manufactured by Alembic Pharmaceuticals Inc., is $0.0770 per EA (NDC 62332014271), effective Nov 18, 2026.

How has the price of CELECOXIB 200 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for CELECOXIB 200 MG CAPSULE has declined 81.8%. It has been tracked across 490 weekly CMS publications since Jul 5, 2017.

What are the highest and lowest recorded NADAC prices for CELECOXIB 200 MG CAPSULE?

Since Jul 5, 2017, the NADAC for CELECOXIB 200 MG CAPSULE has ranged from a low of $0.0749 (Oct 21, 2026) to a high of $0.4244 (Aug 16, 2017), with a median of $0.1436 per EA.

Are there cheaper alternatives to CELECOXIB 200 MG CAPSULE?

Yes. 17 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CELECOXIB 200 MG CAPSULE, is $0.0760 per EA — about 1% below CELECOXIB 200 MG CAPSULE.

Who manufactures CELECOXIB 200 MG CAPSULE?

CELECOXIB 200 MG CAPSULE (NDC 62332014271) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.